Open Save New
FeedNavigator / National Library of Health Sciences
 
  
Tutkijat / Oulu
AddAla-Kokko, L.
AddAla-Kokko, T(ero)
AddAla-Korpela, M(ika)
AddAlahuhta, S.
AddAlen, M.
AddAntikainen, R.
AddAnttonen, V(uokko)
AddBiancari, F.
AddBloigu, R(isto)
AddEskelinen, S.
AddFlinkkilä, T(apio)
AddHakkola, J.
AddHallman, M.
AddHartikainen, A(nna)-L(iisa)
AddHausen, H.
AddHautala, N(ina)
AddHautala, T(imo)
AddHeape, A.
AddHerzig, K(arl)-H(einz)
AddHillbom, M.
AddHiltunen, J.K.
AddHörkko, S.
AddHuikuri, H
AddHukkanen J(anne)
AddIgnatius, J.
AddIsohanni, M.
AddJaakkola, J.
AddJaakkola, M(aritta) S.
AddJaakola, V-P.
AddJämsä, T(imo)
AddJanhonen, S.
AddJärvelin, M(arjo)-R(iitta)
AddJokelainen, J(ari)
AddJuffer, A.H.
AddJunttila, J(uhani)
AddJuvonen, T.
AddKaarteenaho, R(iitta)
AddKajantie, E(ero)*(THL/OY)
AddKarppinen (Koivunen), P(eppi)
AddKarppinen, J(aro)
AddKarttunen, T.J.
AddKeinänen-Kiukaanniemi, S(irkka)
AddKerkelä, R(isto)
AddKesäniemi, Y.A.
AddKettunen, J(ohannes)
AddKietzmann, T(homas).
AddKivirikko, K.I.
AddKnuuttila, M.
AddKoivukangas, J.
AddKursula, P.
AddKyngäs, H.
AddLarivaara, P.
AddLarmas, M.
AddLehenkari, P(etri)
AddLehtiö, L(ari)
AddLeppilahti, J.
AddLuukinen, H.
AddMainio A
AddMajamaa, K.
AddMäki, P(irjo)
AddMäkikallio, T.
AddMännikkö, M(inna)
AddManninen, A(ki).
AddMartikainen, H(annu)
AddMiettunen, J(ouko)
AddMyllyharju, J.
AddMyllylä, R.
AddMyllylä, V.
AddNäyhä, S.
AddNeubauer, P.
AddNieminen, M(iika) T.
AddNieminen, P(entti)
AddNiinimäki, J(aakko)
AddOhukainen, P(auli)
AddOikarinen, A.
AddOikarinen, K.
AddPelkonen, O(lavi)
AddPetäjä-Repo, U.E.
AddPihlajaniemi, T.
AddPirttiniemi, P(ertti)
AddPuistola, U(lla)
AddRajaniemi, H.J.
AddRämet, M(ika)
AddRäsänen, P.
AddRaustia, A.
AddRemes, A(nne)
AddRisteli, J.
AddRistiniemi, J.
AddRuddock, L.W.
AddRuokonen, A.
AddRuskoaho, H.
AddRyynänen, M.
AddSaarakkala, S.
AddSaari, A.
AddSalo, T(uula)
AddSándor, G(eorge) K.
AddSavolainen, E-R.
AddSavolainen, M.J.
AddSavolainen, O.
AddSillanpää, M(ikko).
AddSoininen, R.
AddSorri, M.
AddTaanila, A.
AddTapiainen, T(erhi)
AddTervonen, O(smo)
AddTimonen, M(arkku)
AddTjäderhane, L.
AddTurpeenniemi-Hujanen, T.
AddTuukkanen, J(uha)
AddTuulonen, A.
AddUhari, M.
AddUkkola, O(lavi)
AddUusimaa, J.
AddVainio, O.
AddVainio, S.
AddVeijola, J(uha)
AddVeijola, R(iitta)
AddVirokannas, H.
AddVoipio, H(anna)-M(arja)
AddVuolteenaho, O.
AddWeckström, M.
AddWei, GH.
AddWierenga, R.K.
AddWinqvist, R.
AddYlänne, J.
AddYlitalo, K(ari)

Scholar Chart >>



»My Articles

»Latest Feeds

»Popular Feeds
Search Feed Catalog by Name:

A roadmap for the development of alternative (non-animal) methods for systemic toxicity testing - t4 report*.Pelkonen, O(lavi)3100 dayssaveRefWorks
Significant interspecies differences in induction profiles of hepatic CYP enzymes by TCDD in bank and field voles.Pelkonen, O(lavi)3128 dayssaveRefWorks
Hepatocytes: The powerhouse of biotransformation.Pelkonen, O(lavi)3170 dayssaveRefWorks
In vivo-in vitro-in silico pharmacokinetic modelling in drug development: current status and future directions.Pelkonen, O(lavi)3311 dayssaveRefWorks
Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010.Pelkonen, O(lavi)3381 dayssaveRefWorks
Metabolism of Ophthalmic Timolol: New Aspects of an Old Drug.Pelkonen, O(lavi)3435 dayssaveRefWorks
Metabolism of ?-thujone in human hepatic preparations in vitro.Pelkonen, O(lavi)3545 dayssaveRefWorks
Placental transfer and DNA-binding of benzo(a)pyrene in human placental perfusion.Pelkonen, O(lavi)3734 dayssaveRefWorks
Metabolism of Carbosulfan II. Human Interindividual Variability in its In Vitro Hepatic Biotransformation and the Identification of the Cytochrome P450 Isoforms Involved.Pelkonen, O(lavi)3786 dayssaveRefWorks
Rapid screening of commercially available herbal products for the inhibition of major human hepatic cytochrome P450 enzymes using the N-in-one cocktail.Pelkonen, O(lavi)3798 dayssaveRefWorks
An evaluation of the cytochrome P450 inhibition potential of selected pesticides in human hepatic microsomes.Pelkonen, O(lavi)3812 dayssaveRefWorks
[Why does acetylsalicylic acid have so many effects and applications?]Pelkonen, O(lavi)3843 dayssaveRefWorks
Effects of Selective Serotonin Reuptake Inhibitors on Timolol Metabolism in Human Liver Microsomes and Cryo-Preserved Hepatocytes.Pelkonen, O(lavi)3913 dayssaveRefWorks
Comparison of metabolic stability and metabolite identification of 55 ECVAM/ICCVAM validation compounds between human and rat liver homogenates and microsomes - a preliminary analysis.Pelkonen, O(lavi)3917 dayssaveRefWorks
Effects of pharmaceuticals and other active chemicals at biological targets: mechanisms, interactions, and integration into PB-PK/PD models.Pelkonen, O(lavi)4065 dayssaveRefWorks
Metabolism of Carbosulfan. I. Species Differences in the In Vitro Biotransformation by Mammalian Hepatic Microsomes Including Human.Pelkonen, O(lavi)4067 dayssaveRefWorks
Functional Expression, Inhibition and Induction of CYP Enzymes in HepaRG cells.Pelkonen, O(lavi)4144 dayssaveRefWorks
Expression of cytochrome P450 (CYP) enzymes in human non-pigmented ciliary epithelial cells; induction of CYP1B1 expression by TCDD.Pelkonen, O(lavi)4147 dayssaveRefWorks
Rapid detection and characterization of reactive drug metabolites in vitro using several isotope-labeled trapping agents and ultra-performance liquid chromatography/time-of-flight mass spectrometry.Pelkonen, O(lavi)4184 dayssaveRefWorks
Liquid chromatography-mass spectrometry in in vitro drug metabolite screening.Pelkonen, O(lavi)4256 dayssaveRefWorks
Analysis of nine drugs and their cytochrome P450-specific probe metabolites from urine by liquid chromatography-tandem mass spectrometry utilizing sub 2mum particle size column.Pelkonen, O(lavi)4274 dayssaveRefWorks
Schizophrenia and sudden cardiac death-A review.Pelkonen, O(lavi)4357 dayssaveRefWorks
Local Kinetics and Dynamics of Xenobiotics.Pelkonen, O(lavi)4379 dayssaveRefWorks
Cytochromes P450, induction and cholesterol-what are the connections?Pelkonen, O(lavi)4400 dayssaveRefWorks
Inhibition and induction of human cytochrome P450 enzymes: current status.Pelkonen, O(lavi)4406 dayssaveRefWorks
Coactivator PGC-1alpha regulates the fasting inducible xenobiotic-metabolizing enzyme CYP2A5 in mouse primary hepatocytes.Pelkonen, O(lavi)4410 dayssaveRefWorks
Identification of the human cytochrome P450 enzymes involved in the in vitro biotransformation of lynestrenol and norethindrone.Pelkonen, O(lavi)4518 dayssaveRefWorks
In vitro-in vivo extrapolation of hepatic clearance: Biological tools, scaling factors, model assumptions and correct concentrations.Pelkonen, O(lavi)4661 dayssaveRefWorks
Issues in the design and interpretation of chronic toxicity and carcinogenicity studies in rodents: approaches to dose selection.Pelkonen, O(lavi)4667 dayssaveRefWorks
Risk of retinal microembolism after off-pump and on-pump coronary artery bypass surgery.Pelkonen, O(lavi)4672 dayssaveRefWorks
Predictive value of animal models for human cytochrome P450 (CYP)-mediated metabolism: A comparative study in vitro.Pelkonen, O(lavi)4673 dayssaveRefWorks
Identification of inhibitors of the nicotine metabolising CYP2A6 enzyme-an in silico approach.Pelkonen, O(lavi)4682 dayssaveRefWorks
CHARACTERIZATION OF DIURON N-DEMETHYLATION BY MAMMALIAN HEPATIC MICROSOMES AND cDNA-EXPRESSED HUMAN CYTOCHROME P450 ENZYMES.Pelkonen, O(lavi)4794 dayssaveRefWorks
In vitro interaction cocktail assay for nine major cytochrome P450 enzymes with 13 probe reactions and a single LC/MSMS run: analytical validation and testing with monoclonal anti-CYP antibodies.Pelkonen, O(lavi)4799 dayssaveRefWorks
Aryl Hydrocarbon Receptor Nuclear Translocator and Upstream Stimulatory Factor Regulate Cytochrome P450 2a5 Transcription through a Common E-box Site.Pelkonen, O(lavi)4844 dayssaveRefWorks
Timolol metabolism in human liver microsomes is mediated principally by CYP2D6.Pelkonen, O(lavi)4861 dayssaveRefWorks
Metabolism and pharmacokinetics in children and the elderly.Pelkonen, O(lavi)4862 dayssaveRefWorks
Effect of renal impairment on the pharmacokinetics of bupropion and its metabolites.Pelkonen, O(lavi)4900 dayssaveRefWorks
New potent and selective cytochrome P450 2B6 (CYP2B6) inhibitors based on three-dimensional quantitative structure-activity relationship (3D-QSAR) analysis.Pelkonen, O(lavi)4906 dayssaveRefWorks
[In Process Citation]Pelkonen, O(lavi)4945 dayssaveRefWorks
The Functional Role of CYP2B6 in Human Drug Metabolism: Substrates and Inhibitors In Vitro, In Vivo and In Silico.Pelkonen, O(lavi)5025 dayssaveRefWorks
In vitro screening of drug metabolism during drug development: can we trust the predictions?Pelkonen, O(lavi)5072 dayssaveRefWorks
Metabolic and efflux properties of caco-2 cells stably transfected with nuclear receptors.Pelkonen, O(lavi)5082 dayssaveRefWorks
Polycyclic aromatic hydrocarbon (PAH) metabolizing enzyme activities in human lung, and their inducibility by exposure to naphthalene, phenanthrene, pyrene, chrysene, and benzo(a)pyrene as shown in the rat lung and liver.Pelkonen, O(lavi)5103 dayssaveRefWorks
Cytochrome P450 (CYP) inhibition screening: Comparison of three tests.Pelkonen, O(lavi)5110 dayssaveRefWorks
Estrogen receptor alpha genotype confers interindividual variability of response to estrogen and testosterone in mesenchymal-stem-cell-derived osteoblasts.Pelkonen, O(lavi)5159 dayssaveRefWorks
 XML / RSS feed
report
 « prev   page 2